'urge to pee' pill may be sold in UK without prescription
It would be the first time a medicine for the treatment of overactive bladder would be available without prescription
April 23, 2022, 4:11 pm

'urge to pee' pill may be sold in UK without prescription (Photo: Pixabay)

The BBC reported, pill to help treat an overactive bladder - which affects millions of women - could soon be available to buy in the UK without prescription.

The Medicines and Healthcare products Regulatory Agency (MHRA) wants women and doctors to submit their views.

Aquiette tablets treat the "urge to pee" condition which can cause frequent toilet trips and distressing accidents.

Symptoms include having to urinate at least eight times a day and more than once during the night.

It would be the first time a medicine for the treatment of overactive bladder would be available without prescription.

Dr Laura Squire, from the MHRA, said: "For many women, an overactive bladder can make day-to-day living extremely challenging. It can impact on relationships, on work, on social life, and it can lead to anxiety and depression.

Symptoms include having to urinate at least eight times a day and more than once during the night (Photo: Pixabay)

She added: "Fortunately there are treatments around, and from today you will have a chance to have your say on whether one of those treatments, Aquiette, can be available for the first time without a prescription."

Minister for Women's Health Maria Caulfield said: "When it comes to sensitive issues such as bladder control, speaking to a GP may act as a barrier for some women to seek help.

Report: Muslim women face racial and religious discrimination by UK prison staff

"Reclassification of Aquiette would enable women to access vital medication without needing a prescription."

The Commission on Human Medicines has been consulted and has advised that it is safe for Aquiette to be made available over-the-counter at UK pharmacies.

The consultation will run for three weeks, closing on 6 May, 2022.

There are several types of incontinence, but this medication is designed to treat an overactive bladder condition only.

Boris Johnson: Transgender women should not be competing in female sporting events

Types of urinary incontinence include:

stress incontinence - when urine leaks out at times when your bladder is under pressure, for example, when you cough or laugh

urge incontinence - when urine leaks as you feel a sudden, intense urge to pee, or soon afterwards

overflow incontinence (chronic urinary retention) - when you're unable to fully empty your bladder, which causes frequent leaking

Nawal El-Saadawi A Vindication of the Rights of Arab Women

total incontinence - when your bladder cannot store any urine at all, which causes you to pass urine constantly or have frequent leaking

Source: BBC

Beijing on alert after ten COVID-19 cases discovered in school India warns nationals against studying in any Pakistani college or institution

BENEFIT, the Kingdom’s innovator and leading company in Fintech and electronic financial transactions service, held its Annual General Meeting (AGM) at the company’s headquarters in the Seef District.
During the meeting, shareholders approved all items listed on the agenda, including the ratification of the minutes of the previous AGM held on 26 March 2024. The session reviewed and approved the Board’s Annual Report on the company’s activities and financial performance for the fiscal year ended 31 December 2024, and the shareholders expressed their satisfaction with the company’s operational and financial results during the reporting period.
The meeting also reviewed the Independent External Auditor’s Report on the company’s consolidated financial statements for the year ended 31 December 2024. Subsequently, the shareholders approved the audited financial statements for the fiscal year. Based on the Board’s recommendation, the shareholders approved the distribution of a cash dividend equivalent to 10% of the paid-up share capital.
Furthermore, the shareholders endorsed the allocation of a total amount of BD 172,500 as remuneration to the members of the Board for the year ended 31 December 2024, subject to prior clearance by related authorities.
The extension of the current composition of the Board was approved, which includes ten members and one CBB observer, for a further six-month term, expiring in September 2025, pending no objection from the CBB.
The meeting reviewed and approved the Corporate Governance Report for 2024, which affirmed the company’s full compliance with the corporate governance directives issued by the CBB and other applicable regulatory frameworks. The AGM absolved the Board Members of liability for any of their actions during the year ending on 31st December 2024, in accordance with the Commercial Companies Law.
In alignment with regulatory requirements, the session approved the reappointment of Ernst & Young (EY) as the company’s External Auditors for the fiscal year 2025, covering both the parent company and its subsidiaries—Sinnad and Bahrain FinTech Bay. The Board was authorised to determine the external auditors’ professional fees, subject to approval from the CBB, and the meeting concluded with a discussion of any additional issues as per Article (207) of the Commercial Companies Law.
Speaking on the company’s performance, Mr. Mohamed Al Bastaki, Chairman BENEFIT , stated: “In terms of the financial results for 2024, I am pleased to say that the year gone by has also been proved to be a success in delivering tangible results. Growth rate for 2024 was 19 per cent. Revenue for the year was BD 17 M (US$ 45.3 Million) and net profit was 2 Million ($ 5.3 Million).

Mr. Al Bastaki also announced that the Board had formally adopted a new three-year strategic roadmap to commence in 2025. The strategy encompasses a phased international expansion, optimisation of internal operations, enhanced revenue diversification, long-term sustainability initiatives, and the advancement of innovation and digital transformation initiatives across all service lines.
“I extend my sincere appreciation to the CBB for its continued support of BENEFIT and its pivotal role in fostering a stable and progressive regulatory environment for the Kingdom’s banking and financial sector—an environment that has significantly reinforced Bahrain’s standing as a leading financial hub in the region,” said Mr. Al Bastaki. “I would also like to thank our partner banks and valued customers for their trust, and our shareholders for their ongoing encouragement. The achievements of 2024 set a strong precedent, and I am confident they will serve as a foundation for yet another successful and impactful year ahead.”
Chief Executive of BENEFIT; Mr. Abdulwahed AlJanahi commented, “The year 2024 represented another pivotal chapter in BENEFIT ’s evolution. We achieved substantial progress in advancing our digital strategy across multiple sectors, while reinforcing our long-term commitment to the development of Bahrain’s financial services and payments landscape. Throughout the year, we remained firmly aligned with our objective of delivering measurable value to our shareholders, strategic partners, and customers. At the same time, we continued to play an active role in enabling Bahrain’s digital economy by introducing innovative solutions and service enhancements that directly address market needs and future opportunities.”
Mr. AlJanahi affirmed that BENEFIT has successfully developed a robust and well-integrated payment network that connects individuals and businesses across Bahrain, accelerating the adoption of emerging technologies in the banking and financial services sector and reinforcing Bahrain’s position as a growing fintech hub, and added, “Our achievements of the past year reflect a long-term vision to establish a resilient electronic payment infrastructure that supports the Kingdom’s digital economy. Key developments in 2024 included the implementation of central authentication for open banking via BENEFIT Pay”
Mr. AlJanahi concluded by thanking the Board for its strategic direction, the company’s staff for their continued dedication, and the Central Bank of Bahrain, member banks, and shareholders for their valuable partnership and confidence in the company’s long-term vision.